Clinical trial
Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian…
NCT00384072 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00384072 |
|---|---|
| Title | Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women |
| Official title | A Multicenter, Double Blind, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Postmenopause, Osteoporosis |
| Intervention type | Drug |
| Interventions | bazedoxifene BZA-20 |
| Enrollment | 500 |
| Start date | May 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Oct 4, 2006 |
| Last update posted | Dec 28, 2007 |
| Countries | China, South Korea, Taiwan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: